2024年12月3日，上海——复宏汉霖（2696.HK）宣布，公司自主研发的创新型抗PD-1单抗H药 汉斯状（通用名：斯鲁利单抗注射液）正式获得国家药品监督管理局（NMPA）批准，联合培美曲塞和卡铂适用于表皮生长因子受体（EGFR）基因突变阴性和间变性淋巴瘤激酶（ALK）阴性的不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌（nsNSCLC）的一线治疗。这是H药在中国获批的第五项适应症，也是继鳞状 ...

Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...

Oct. 28, 2024 — Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing function. These preclinical ...

TYK Medicines Inc. has identified proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase-binding moiety covalently bonded to an EGFR (mutant)-targeting moiety through a ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), reports an update on the Phase III SKYSCRAPER-01 study, ...

Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.

Research indicates that people with a family history of lung cancer have an increases risk, even without direct tobacco exposure. Specific genetic mutations, such as those found in the EGFR gene, are ...

Susan Wojcicki, the late CEO of YouTube, had a message for the world just weeks before she passed. “Although lung cancer ...

A technology has been developed that can analyze tumor mutations in lung cancer patients to confirm drug resistance to ...

Explore the challenges and advancements in anti-EGFR antibody treatment for metastatic colorectal cancer. Discover how ...

China’s drug regulator approved Alpha Biopharma Ltd.’s EGFR tyrosine kinase inhibitor (TKI), Zorifer (zorifertinib hydrochloride tablets; AZD-3759), as a first-line treatment for EGFR-mutated ...